Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
6/02 | 1,820 USD
+6,43% |
+6,43% |
|
Cabaletta Bio Inc |
6/02 | 2,510 USD
+7,73% |
+7,73% |
|
Calithera Biosciences Inc |
6/02 | 0,000 USD
0,00% |
0,00% |
Cambridge Cognition Holdings plc |
6/02 | 39,000 GBX
+6,85% |
+6,85% |
|
Can-Fite Biopharma Ltd |
6/02 | 4,160 USD
-2,12% |
-2,12% |
|
Capricor Therapeutics Inc |
6/02 | 24,720 USD
+7,34% |
+7,34% |
Carbios |
6/02 | 9,845 EUR
+2,02% |
+2,02% |
Cardiol Therapeutics Inc - Class A |
6/02 | 1,370 CAD
+4,58% |
+4,58% |
|
Caredx Inc |
6/02 | 19,470 USD
+6,10% |
+6,10% |
|
Carisma Therapeutics, Inc. |
6/02 | 0,039 USD
0,00% |
0,00% |
|
Carmat |
26/09 | 0,099 EUR
0,00% |
0,00% |
|
CASI Pharmaceuticals Inc |
6/02 | 0,925 USD
-2,66% |
-2,66% |
|
Cassava Sciences Inc |
6/02 | 2,030 USD
+7,41% |
+7,41% |
|
Castle Biosciences Inc |
6/02 | 32,750 USD
+1,08% |
+1,08% |
|
Catalyst Pharmaceuticals Inc |
6/02 | 24,440 USD
+2,22% |
+2,22% |
|
Cel-Sci Corp. |
6/02 | 5,000 USD
+2,04% |
+2,04% |
|
Celldex Therapeutics Inc. |
6/02 | 23,760 USD
+5,23% |
+5,23% |
|
Cellectar Biosciences Inc |
6/02 | 3,040 USD
+7,80% |
+7,80% |
|
Cellectis |
6/02 | 3,570 USD
+2,00% |
+2,00% |
|
Cellectis |
6/02 | 3,105 EUR
-1,58% |
-1,58% |
Celyad Oncology |
6/02 | 0,180 EUR
-1,10% |
-1,10% |
|
Cerus Corp. |
6/02 | 2,200 USD
+2,80% |
+2,80% |
|
Champions Oncology Inc |
6/02 | 6,550 USD
+0,31% |
+0,31% |
|
Charlottes Web Holdings Inc |
6/02 | 0,710 CAD
+10,94% |
+10,94% |
|
China Pharma Holdings Inc. |
6/02 | 0,694 USD
+10,14% |
+10,14% |
|
China SXT Pharmaceuticals Inc |
6/02 | 3,000 USD
+6,38% |
+6,38% |
|
Cidara Therapeutics Inc |
6/01 | 221,380 USD
+0,03% |
+0,03% |
|
Cipher Pharmaceuticals Inc |
6/02 | 14,400 CAD
0,00% |
0,00% |
|
Citius Pharmaceuticals Inc |
6/02 | 0,755 USD
+6,00% |
+6,00% |
|
Clean Air Metals Inc |
6/02 | 0,090 CAD
+12,50% |
+12,50% |
|
ClearPoint Neuro Inc |
6/02 | 13,460 USD
+7,08% |
+7,08% |
|
Clearside Biomedical Inc |
6/02 | 0,650 USD
0,00% |
0,00% |
|
Cns Pharmaceuticals Inc |
6/02 | 4,510 USD
-0,88% |
-0,88% |
|
Co-Diagnostics Inc |
6/02 | 2,330 USD
-0,85% |
-0,85% |
|
Cocrystal Pharma Inc |
6/02 | 0,970 USD
+12,76% |
+12,76% |
|
Cogent Biosciences Inc |
6/02 | 37,080 USD
+3,87% |
+3,87% |
|
Coherus Biosciences Inc |
6/02 | 2,140 USD
+2,39% |
+2,39% |
|
Collegium Pharmaceutical Inc |
6/02 | 47,610 USD
+1,47% |
+1,47% |
|
CollPlant Biotechnologies Ltd |
6/02 | 0,800 USD
+6,65% |
+6,65% |
Coloplast |
6/02 | 66,780 EUR
-7,61% |
-7,61% |
|
Compass Pathways Plc |
6/02 | 6,190 USD
+8,41% |
+8,41% |
|
Compass Therapeutics Inc |
6/02 | 6,520 USD
+4,82% |
+4,82% |
|
Compugen Ltd. |
6/02 | 1,670 USD
+5,03% |
+5,03% |
|
Conmed Corp. |
6/02 | 41,520 USD
+2,12% |
+2,12% |
|
Convatec Group |
6/02 | 225,600 GBX
-0,70% |
-0,70% |
|
Cooper Companies, Inc. |
6/02 | 82,100 USD
+2,50% |
+2,50% |
|
Corbus Pharmaceuticals Holdings Inc |
6/02 | 7,830 USD
+5,95% |
+5,95% |
|
Corcept Therapeutics Inc |
6/02 | 40,830 USD
+6,44% |
+6,44% |
|
CorMedix Inc |
6/02 | 7,690 USD
+4,63% |
+4,63% |
|
Corvus Pharmaceuticals Inc |
6/02 | 20,460 USD
+7,35% |
+7,35% |
|
Covalon Technologies Ltd. |
6/02 | 1,590 CAD
-1,24% |
-1,24% |
|
Creo Medical Group Plc |
6/02 | 17,750 GBX
+1,43% |
+1,43% |
|
Crescita Therapeutics Inc |
6/02 | 0,500 CAD
-3,85% |
-3,85% |
|
Crinetics Pharmaceuticals Inc |
6/02 | 45,280 USD
+1,09% |
+1,09% |
|
CRISPR Therapeutics AG |
6/02 | 48,740 USD
+6,23% |
+6,23% |
|
Cronos Group Inc |
6/02 | 2,640 USD
+3,12% |
+3,12% |
|
Crossject |
6/02 | 2,035 EUR
-6,65% |
-6,65% |
|
Cryo-Cell International, Inc. |
6/02 | 3,380 USD
+0,30% |
+0,30% |
|
Cue Biopharma Inc |
6/02 | 0,320 USD
+1,27% |
+1,27% |
|
Cumberland Pharmaceuticals Inc. |
6/02 | 3,910 USD
+8,91% |
+8,91% |
|
CureVac N.V. |
5/01 | 4,660 USD
-0,21% |
-0,21% |
|
Curis Inc |
6/02 | 1,030 USD
+13,11% |
+13,11% |
|
Currenc Group Inc. |
6/02 | 1,440 USD
+3,60% |
+3,60% |
|
Cyanotech Corp. |
6/02 | 0,465 USD
-7,92% |
-7,92% |
|
Cyclerion Therapeutics Inc |
6/02 | 1,100 USD
+1,85% |
+1,85% |
|
Cytokinetics Inc |
6/02 | 62,340 USD
+3,49% |
+3,49% |
|
CytomX Therapeutics Inc |
6/02 | 5,670 USD
+8,21% |
+8,21% |
|
Cytosorbents Corp |
6/02 | 0,672 USD
+6,62% |
+6,62% |